Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 794078, 16 pages
http://dx.doi.org/10.1155/2014/794078
Review Article

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis

1Institute of Cardiovascular Sciences, University of Manchester, Manchester Royal Infirmary, Manchester M13 9WL, UK
2Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK
3Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK

Received 24 August 2013; Accepted 18 December 2013; Published 2 March 2014

Academic Editors: J.-T. Cheng and G. Helft

Copyright © 2014 Chun Shing Kwok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Heerajnarain Bulluck, Chun Shing Kwok, Alisdair D. Ryding, and Yoon K. Loke, “Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials,” International Journal of Cardiology, 2014. View at Publisher · View at Google Scholar
  • Qing-Yu Huang, Madhab Bista, and Ren-Qiang Yang, “Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?,” Medical Principles And Practice, vol. 24, no. 4, pp. 398–398, 2015. View at Publisher · View at Google Scholar
  • Gustavo Bruniera, Cristóvão Mangueira, Carlos Senne, Renan Domingues, and Fernando Brunale, “Lumbar puncture in patients using anticoagulants and antiplatelet agents,” Arquivos de Neuro-Psiquiatria, vol. 74, no. 8, pp. 679–686, 2016. View at Publisher · View at Google Scholar
  • Cheng Xie, Xiao-Liang Ding, and Li-Yan Miao, “Different durations of dual anti-platelet therapy after percutaneous coronary intervention with drug-eluting stents in patients with coronary disease: A systematic review,” Chinese Pharmaceutical Journal, vol. 51, no. 9, pp. 762–768, 2016. View at Publisher · View at Google Scholar
  • He Huang, Ya Li, and Meina Sun, “Shorter (≤6 months) vs. longer (≥12 months) dual antiplatelet therapy after second-generation drug-eluting stents implantation: a meta-analysis of randomized controlled trials,” European Heart Journal Supplements, vol. 18, no. supplA, pp. A54–A62, 2016. View at Publisher · View at Google Scholar
  • Meghana Halkar, and A. Michael Lincoff, “Dual antiplatelet therapy for acute coronary syndromes: How long to continue?,” Cleveland Clinic Journal of Medicine, vol. 83, no. 9, pp. 675–688, 2016. View at Publisher · View at Google Scholar
  • Bredy-Pierre-Louis, Damian Kurian, Olusegun Sheyin, and Xavier Perez, “The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents,” Cardiology Journal, vol. 23, no. 3, pp. 307–316, 2016. View at Publisher · View at Google Scholar
  • Wei Wang, Jing Liu, Jingxue Fang, Yang Liu, Tong An, Meijuan Zou, and Gang Cheng, “The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials,” International Journal of Cardiology, vol. 235, pp. 73–86, 2017. View at Publisher · View at Google Scholar
  • Yuejin Yang, Peisen Huang, Yuan Yu, and Xikun Han, “Efficacy of Short-term Dual Antiplatelet Therapy after Implantation of Second-generation Drug-eluting Stents: A Meta-analysis and Systematic Review,” Chinese Medical Sciences Journal, vol. 32, no. 1, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • Luc Maillard, Nicolas Barra, Jacques Billé, Patrick Joly, Marc Silvestri, François Vochelet, Alain Tavildari, and Patrick Peycher, “Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent,” Archives of Cardiovascular Diseases, vol. 110, no. 12, pp. 682–688, 2017. View at Publisher · View at Google Scholar
  • Jorge Guillermo Velásquez, Fernando Guerrero Pinedo, Mayra Alejandra Estacio, Isabela Vergara, Sebastián Yara, and Diana Cristina Carrillo, “Incidencia de eventos cardiovasculares mayores asociada a la suspensión de doble terapia antiagregante en pacientes con enfermedad coronaria e implante de stent,” Revista Colombiana de Cardiología, 2017. View at Publisher · View at Google Scholar